Axa’s Mimecast Limited MIME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-63,900
Closed -$5.08M 1264
2021
Q4
$5.08M Buy
+63,900
New +$4.81M 0.01% 662
2021
Q3
Sell
-6,800
Closed -$361K 1354
2021
Q2
$361K Hold
6,800
﹤0.01% 1146
2021
Q1
$273K Sell
6,800
-296,000
-98% -$13M ﹤0.01% 1155
2020
Q4
$17.2M Buy
302,800
+33,800
+13% +$1.56M 0.05% 366
2020
Q3
$12.6M Buy
269,000
+26,000
+11% +$1.18M 0.05% 390
2020
Q2
$10.1M Hold
243,000
0.04% 428
2020
Q1
$8.58M Buy
243,000
+43,000
+22% +$1.86M 0.04% 394
2019
Q4
$8.68M Hold
200,000
0.04% 484
2019
Q3
$7.13M Hold
200,000
0.03% 548
2019
Q2
$9.34M Hold
200,000
0.04% 492
2019
Q1
$9.47M Hold
200,000
0.04% 468
2018
Q4
$6.73M Buy
200,000
+24,000
+14% +$838K 0.03% 527
2018
Q3
$7.37M Buy
+176,000
New +$7.15M 0.03% 560

Other funds holding MIME

Axa's MIME Position: Q1 2022 in Review

Axa sold out of Mimecast Limited (MIME) in Q1 2022, closing a stake of 63,900 shares — an estimated $5.08M sold.

Axa first reported a position in MIME in Q3 2018 and held it in 13 quarters. The position peaked at $17.2M in Q4 2020. 271 funds tracked by Wall St. Rank hold MIME as of Q1 2022.

  • Axa reported no remaining Mimecast Limited position as of Q1 2022 after selling out during the quarter.
  • Axa sold 63,900 Mimecast Limited shares in Q1 2022, an estimated $5.08M.
  • Axa first reported a position in Mimecast Limited in Q3 2018 and held it in 13 quarters.
  • Axa's Mimecast Limited position peaked at $17.2M in Q4 2020.
  • 271 funds tracked by Wall St. Rank held Mimecast Limited as of Q1 2022.

Based on Axa's 13F filing for Q1 2022, filed 13 May 2022.